adenosine monophosphate has been researched along with Hodgkin Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, H; Goda, S; Hiraoka, N; Matsumoto, Y; Matsuyama, A; Omura, A; Ono, S; Shiotsu, S; Suga, Y; Sugitani, M; Takumi, C; Tanaka, S; Tsuji, T; Yuba, T | 1 |
Bömer, H; Metzger, E; Sauer, O; Schneider, H; Schubert, E; Treuner, J; Werner, GT | 1 |
2 other study(ies) available for adenosine monophosphate and Hodgkin Disease
Article | Year |
---|---|
Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report.
Topics: Adenosine Monophosphate; Adult; Alanine; Amides; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Brentuximab Vedotin; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Dacarbazine; Disease Progression; Doxorubicin; Hodgkin Disease; Humans; Male; Pregnenediones; Pyrazines; Time Factors; Vinblastine | 2021 |
[The virostatic effect of adenine-arabinoside monophosphate. Experimental findings and preliminary clinical experiences].
Topics: Adenosine Monophosphate; Animals; Child; Child, Preschool; Encephalitis; Female; Herpes Simplex; Herpes Zoster; Hodgkin Disease; Humans; Infant; Leukemia; Male; Mice; Rabbits; Solubility; Vaccinia; Vidarabine | 1978 |